Schonfeld Strategic Advisors LLC Takes Position in Trupanion, Inc. (NASDAQ:TRUP)

Schonfeld Strategic Advisors LLC bought a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 21,100 shares of the financial services provider's stock, valued at approximately $1,017,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of Trupanion by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock valued at $173,362,000 after buying an additional 45,653 shares during the last quarter. Marshall Wace LLP lifted its holdings in shares of Trupanion by 6.9% during the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider's stock valued at $43,459,000 after acquiring an additional 57,804 shares during the period. Baillie Gifford & Co. grew its holdings in shares of Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock worth $33,806,000 after purchasing an additional 147,341 shares during the last quarter. Northern Trust Corp increased its stake in shares of Trupanion by 9.0% in the 4th quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock valued at $17,749,000 after buying an additional 30,549 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in Trupanion by 2.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 306,752 shares of the financial services provider's stock worth $14,785,000 after purchasing an additional 6,338 shares during the period.

Insider Buying and Selling

In other Trupanion news, CFO Fawwad Qureshi sold 1,373 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the transaction, the chief financial officer now directly owns 2,416 shares in the company, valued at $82,675.52. This represents a 36.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Margaret Tooth sold 4,000 shares of the firm's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $33.34, for a total value of $133,360.00. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $3,960,258.56. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,792 shares of company stock worth $1,122,802 in the last three months. Corporate insiders own 5.50% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on TRUP. Lake Street Capital cut their target price on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Piper Sandler reduced their price objective on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Finally, Stifel Nicolaus lowered their price objective on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $51.80.

Trupanion Stock Performance

TRUP traded up $0.58 during mid-day trading on Monday, reaching $44.85. 236,779 shares of the company traded hands, compared to its average volume of 644,075. The company's fifty day moving average price is $36.70 and its 200-day moving average price is $44.49. The stock has a market capitalization of $1.92 billion, a P/E ratio of -194.63, a P/E/G ratio of 6.02 and a beta of 1.72. Trupanion, Inc. has a 52-week low of $25.90 and a 52-week high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02. The firm had revenue of $341.98 million during the quarter, compared to analysts' expectations of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The company's quarterly revenue was up 11.7% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.16) EPS. On average, sell-side analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.